Journal Report

Journal of Cancer Metastasis and Treatment

Download PDF
Journal Information
Journal Title
Journal of Cancer Metastasis and Treatment
Publisher
OAE Publishing Inc.
ISSN
2394-4722
E-ISSN
2454-2857
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓
2025 ✓
2024 ✓
2023 ✓
2021/2022
2020
2019
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Feature interview with Dr. William C. Cho - “Clarivate 2023 highly cited researcher”
Frida Xu
2024 Vol. 9 Pages 43
DOI: 10.20517/2394-4722.2024.04
Research advances in immunotherapy combined with DNA damage response inhibitors for liver cancer therapy
Chen Yang, Tao Tao, Yijie Wu et al.
2024 Vol. 10 Pages 14
DOI: 10.20517/2394-4722.2023.175
Integration of community pharmacies in an Italian colorectal cancer screening program: insights from the Local Health Authority of Bologna
Angela Chiereghin, Lorenzo Pizzi, Tiziana Sanna et al.
2024 Vol. 10 Pages 9
DOI: 10.20517/2394-4722.2023.118
Clinical resistance predictors to first-line VEGFR-TKI monotherapy for metastatic renal cell carcinoma: a retrospective multicenter real-life case series
Pezzicoli Gaetano, Quaglini Silvana, Tibollo Valentina et al.
2023 Vol. 9 Pages 35
DOI: 10.20517/2394-4722.2023.41
Role of epithelial-mesenchymal transition factor SNAI1 and its targets in ovarian cancer aggressiveness
Tise Suzuki, Ashlyn Conant, Casey Curow et al.
2023 Vol. 9 Pages 25
DOI: 10.20517/2394-4722.2023.34
Tricking the tumour microenvironment into becoming our best rational drug design factory: reversal of immune suppression
Martin L. Ashdown
2022
DOI: 10.20517/2394-4722.2022.01
Diffuse large B-Cell lymphoma: from novel molecular classifications to tailored targeted therapies
Jennifer K. Lue, Grzegorz S. Nowakowski
2022
DOI: 10.20517/2394-4722.2021.193
Moving towards the chemo-free treatment of lymphoma: hype or reality?
Bruce D. Cheson
2022
DOI: 10.20517/2394-4722.2021.153
Serum squamous cell carcinoma antigen is a predictive factor of outcomes in patients with locally advanced unresectable esophageal squamous cell carcinoma treated by definitive chemoradiotherapy
Takeshi Suzuki, Akihiko Okamura, Masayuki Watanabe et al.
2022
DOI: 10.20517/2394-4722.2021.160
The role of radiotherapy in metastatic bladder cancer
Jananie Perera, Peter Hoskin
2022
DOI: 10.20517/2394-4722.2021.167
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 6, 2026 19:48